Hypertriglyceridaemia is a condition where the blood carries too many triglycerides – a type of fat that fuels the body. When levels rise beyond healthy limits, the risk of heart disease increases, and in severe cases, dangerous inflammation of the pancreas can occur. Managing this condition often begins with changes to diet, physical activity, and weight, though medications may be needed to protect the heart and prevent complications.

How treatment helps protect your health

The main goal of treating hypertriglyceridaemia is to reduce the risk of serious health problems. When triglyceride levels remain elevated for a long time, they contribute to the buildup of fatty deposits in blood vessel walls, a process known as atherosclerosis. This narrowing of arteries raises the chance of heart attacks and strokes. In people with very high triglyceride levels—particularly those reaching 500 milligrams per deciliter or more—there is also a significant risk of acute pancreatitis, a painful and potentially life-threatening swelling of the pancreas that requires urgent medical attention.^[1][2]

Treatment approaches depend on how high the triglyceride levels are and what other health conditions are present. For most people with mildly or moderately elevated levels—between 150 and 499 milligrams per deciliter—the focus is on lowering cardiovascular risk through lifestyle modifications and, if necessary, medications that target cholesterol. For those with severely elevated levels of 500 milligrams per deciliter or higher, rapid reduction of triglycerides becomes urgent to prevent pancreatitis.^[3]

Medical societies, including the National Cholesterol Education Program and the American Heart Association, have issued guidelines emphasizing the importance of addressing high triglycerides as part of overall heart disease prevention. These recommendations recognize that many people with elevated triglycerides also have other risk factors, such as low levels of “good” HDL cholesterol, high “bad” LDL cholesterol, obesity, diabetes, or metabolic syndrome. Treating hypertriglyceridaemia is therefore often part of a broader strategy to manage multiple cardiovascular threats at once.^[2][3]

It’s important to understand that hypertriglyceridaemia itself usually causes no symptoms. Most people discover they have it through routine blood tests. In rare cases of extremely high levels, some individuals may develop small fatty bumps on the skin called xanthomas, or notice changes in the eyes such as a milky appearance of the blood vessels in the retina. But for the vast majority, the condition is silent, making regular screening and proactive management all the more critical.^[1][4]

Standard treatment approaches

The cornerstone of managing hypertriglyceridaemia is making changes to daily habits. These lifestyle modifications are recommended for everyone with elevated triglyceride levels, regardless of whether medications are also prescribed. The reason is simple: changes in diet, physical activity, alcohol consumption, and weight have a direct and powerful effect on triglyceride levels, often lowering them by 20 to 70 percent when consistently applied.^[3][9]

Dietary adjustments are especially effective. Reducing intake of refined carbohydrates and added sugars is one of the most important steps, because when the body takes in more carbohydrates than it can use immediately, it converts the excess into triglycerides. Foods like sugary drinks, desserts, white bread, and sweets should be limited. Instead, eating more whole grains, vegetables, lean proteins, and healthy fats—particularly omega-3 fatty acids found in fish—can help bring levels down. Losing just 5 to 10 percent of body weight, if overweight, can reduce triglycerides by about 20 percent.^[3][13]

Alcohol consumption is another key factor. Even moderate drinking can significantly raise triglyceride levels in some people. For those with hypertriglyceridaemia, cutting down on alcohol or avoiding it entirely is often recommended. Similarly, regular physical activity—aiming for at least 150 minutes of moderate-intensity exercise per week—helps the body use triglycerides for energy and improves overall heart health.^[3][9]

When lifestyle changes alone are not enough to bring triglyceride levels into a safe range, or when cardiovascular risk is high, medications may be added. The choice of medication depends on the triglyceride level and whether other lipid abnormalities, such as high LDL cholesterol, are present.

Statins are a class of drugs primarily used to lower LDL cholesterol, but they also reduce triglycerides by 20 to 40 percent. Common statins include atorvastatin, simvastatin, rosuvastatin, and pravastatin. Statins work by blocking an enzyme in the liver that produces cholesterol, and they have been proven to reduce the risk of heart attacks and strokes. They are often the first-line medication for people with moderately elevated triglycerides who also have high LDL cholesterol or other cardiovascular risk factors. Side effects can include muscle pain, liver enzyme elevations, and, rarely, a serious muscle breakdown condition called rhabdomyolysis.^[9][10]

Fibrates are medications specifically designed to lower triglycerides. They can reduce levels by 40 to 60 percent. The two main fibrates available are fenofibrate and gemfibrozil. Fibrates work by activating certain receptors in the liver that increase the breakdown of triglyceride-rich particles and reduce their production. They are especially useful for people with very high triglyceride levels who need rapid reduction to prevent pancreatitis. Fibrates can also raise HDL cholesterol modestly. The main side effect is an increased risk of muscle problems, particularly if combined with statins. Gemfibrozil in particular should not be used with statins due to this risk, though fenofibrate is considered safer in combination.^[9][10]

Niacin, also known as nicotinic acid or vitamin B3, can lower triglycerides by 30 to 50 percent and also raise HDL cholesterol. However, niacin causes flushing and warmth in the skin, which many people find uncomfortable. It can also worsen blood sugar control in people with diabetes and may raise liver enzymes. For these reasons, niacin is used less commonly today than in the past.^[9]

Omega-3 fatty acids from fish oil can lower triglycerides when taken in high doses—typically 2 to 4 grams per day. Prescription formulations of omega-3 fatty acids are available, including high-purity eicosapentaenoic acid (EPA) preparations. These are often recommended for people with persistently high triglycerides despite other treatments. Over-the-counter fish oil supplements may also help, but they vary widely in purity and concentration.^[9][10]

Before starting medication, doctors typically screen for underlying conditions that can raise triglycerides. These include poorly controlled diabetes, hypothyroidism (underactive thyroid), kidney disease, and certain medications such as beta blockers, diuretics, steroids, oral estrogen, and some chemotherapy drugs. Addressing these secondary causes can sometimes bring triglyceride levels down without the need for additional lipid-lowering drugs.^[2][10]

Treatment duration varies. For people with moderately elevated triglycerides and cardiovascular risk, statin therapy is usually long-term, continuing indefinitely to maintain protection against heart disease. For those with severely elevated levels, fibrates or omega-3 fatty acids may be used temporarily until levels stabilize, or they may be continued long-term depending on the underlying cause.

Treatment in clinical trials

While standard therapies have been used for decades, researchers continue to explore new ways to lower triglycerides more effectively and reduce cardiovascular events. Several innovative treatments are being tested in clinical trials, offering hope for people who do not respond well to existing medications or who need additional options.

One of the most significant recent advances comes from a large clinical trial called REDUCE-IT, which tested a purified form of omega-3 fatty acid called icosapent ethyl (also known by the brand name Vascepa). This is a highly purified preparation of eicosapentaenoic acid, or EPA, given at a dose of 4 grams per day. The trial enrolled more than 8,000 patients with established cardiovascular disease or diabetes who were already taking statins but still had triglyceride levels between 150 and 499 milligrams per deciliter. Over five years of follow-up, the patients who received icosapent ethyl had a significant reduction in major cardiovascular events, including heart attacks, strokes, and cardiovascular death. The number needed to treat to prevent one cardiovascular death was 111, meaning that for every 111 patients treated for five years, one cardiovascular death was prevented.^[3][18]

This was the first major trial to show that lowering triglycerides with a specific therapy reduced cardiovascular mortality in high-risk patients. The results have led to regulatory approval of icosapent ethyl in the United States and other countries for people with elevated triglycerides and high cardiovascular risk who are already on statins. However, the therapy is costly, and discussions continue about its cost-effectiveness compared to other interventions.^[3]

Another area of active research involves therapies that target specific enzymes or proteins involved in triglyceride metabolism. One such target is apolipoprotein C-III, or apoC-III, a protein that inhibits the breakdown of triglyceride-rich lipoproteins. When apoC-III levels are high, triglycerides accumulate in the blood. Researchers have developed antisense oligonucleotides—short pieces of synthetic genetic material—that block the production of apoC-III. In clinical trials, these drugs have dramatically reduced triglyceride levels, sometimes by more than 70 percent, and have shown a good safety profile. These therapies are being tested in Phase II and Phase III trials, particularly for people with very high triglycerides or genetic forms of hypertriglyceridaemia.^[10]

Gene therapy is also being explored for rare genetic conditions that cause extremely high triglycerides, such as familial chylomicronemia syndrome. This is a very rare disorder caused by mutations in genes responsible for breaking down triglycerides, leading to levels often exceeding 1,000 milligrams per deciliter and frequent episodes of pancreatitis. Standard medications are often ineffective. Researchers are investigating whether introducing a working copy of the defective gene—such as the gene for lipoprotein lipase, the key enzyme that breaks down triglycerides—can restore normal triglyceride metabolism. Early trials have shown some promise, but challenges remain in achieving lasting effects and ensuring safety.^[2]

Other experimental therapies in earlier stages of testing include drugs that mimic the action of natural hormones or proteins that regulate fat metabolism. For example, ANGPTL3 inhibitors are being studied. ANGPTL3 is a protein that suppresses lipoprotein lipase, so blocking it can enhance triglyceride breakdown. In Phase I and Phase II trials, ANGPTL3 inhibitors have shown reductions in triglycerides and LDL cholesterol, with few side effects reported so far.

In emergency situations, such as when someone develops acute pancreatitis due to extremely high triglycerides, a procedure called plasmapheresis or apheresis may be used. This involves filtering the blood to physically remove triglyceride-rich lipoproteins. It is not a treatment for long-term management, but it can quickly bring dangerously high levels down within hours, helping to resolve the pancreatitis. Apheresis is typically performed in specialized hospital settings and is reserved for the most severe cases, particularly when triglycerides remain above 1,000 milligrams per deciliter despite initial treatment with medications, insulin infusions, and dietary restriction.^[12][18]

Clinical trials for hypertriglyceridaemia are ongoing in many countries, including the United States, Europe, and other regions. Eligibility for trials often depends on the severity of hypertriglyceridaemia, the presence of other health conditions like diabetes or heart disease, and whether standard treatments have been tried. Some trials are looking for people with rare genetic forms of the condition, while others focus on those with more common, lifestyle-related hypertriglyceridaemia who have not achieved their treatment goals.

Most common treatment methods

• Lifestyle modifications
  • Dietary changes including reduced refined carbohydrates, added sugars, and alcohol; increased omega-3 fatty acids from fish
  • Weight loss of 5 to 10 percent of body weight can reduce triglycerides by about 20 percent
  • Regular moderate-intensity aerobic exercise for at least 150 minutes per week
  • Smoking cessation
• Statins
  • Atorvastatin, simvastatin, rosuvastatin, pravastatin, lovastatin, fluvastatin
  • Reduce triglycerides by 20 to 40 percent and lower LDL cholesterol by 18 to 55 percent
  • Used primarily for people with high cardiovascular risk or elevated LDL cholesterol
  • Possible side effects include muscle pain, liver enzyme elevations, and rarely rhabdomyolysis
• Fibrates
  • Fenofibrate and gemfibrozil
  • Reduce triglycerides by 40 to 60 percent
  • Used for people with very high triglyceride levels (500 milligrams per deciliter or higher) to prevent pancreatitis
  • Can increase HDL cholesterol by 15 to 25 percent
  • Risk of muscle problems, especially if combined with statins; gemfibrozil should not be used with statins
• Omega-3 fatty acids
  • Prescription formulations including icosapent ethyl (purified EPA) and omega-3-acid ethyl esters
  • High doses of 2 to 4 grams per day can reduce triglycerides by 30 to 50 percent
  • Icosapent ethyl at 4 grams daily shown to reduce cardiovascular death in high-risk patients already on statins (REDUCE-IT trial)
  • Generally well tolerated; possible side effects include fishy aftertaste and digestive upset
• Niacin
  • Also called nicotinic acid or vitamin B3
  • Reduces triglycerides by 30 to 50 percent and raises HDL cholesterol by 20 to 30 percent
  • Causes flushing, warmth, and itching in many people; can worsen blood sugar control in diabetics
  • Used less commonly today due to side effects and lack of proven cardiovascular benefit in recent trials
• Experimental therapies in clinical trials
  • Apolipoprotein C-III antisense oligonucleotides to block production of a protein that inhibits triglyceride breakdown
  • ANGPTL3 inhibitors to enhance lipoprotein lipase activity
  • Gene therapy for familial chylomicronemia syndrome
  • Plasmapheresis or apheresis for emergency reduction of extremely high triglycerides in acute pancreatitis